| Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells D Veigel, R Wagner, G Stübiger, M Wuczkowski, M Filipits, R Horvat, ... International journal of cancer 136 (9), 2078-2090, 2015 | 82 | 2015 |
| Abdominal, multi-organ, auto-contouring method for online adaptive magnetic resonance guided radiotherapy: An intelligent, multi-level fusion approach F Liang, P Qian, KH Su, A Baydoun, A Leisser, S Van Hedent, JW Kuo, ... Artificial intelligence in medicine 90, 34-41, 2018 | 58 | 2018 |
| Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks S Rasul, M Hacker, E Kretschmer-Chott, A Leisser, B Grubmüller, ... European journal of nuclear medicine and molecular imaging 47, 713-720, 2020 | 55 | 2020 |
| Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [68Ga] Ga-Pentixafor-PET/MRI AR Haug, A Leisser, W Wadsak, M Mitterhauser, S Pfaff, S Kropf, ... Theranostics 9 (12), 3653, 2019 | 44 | 2019 |
| Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [11C]acetate PET as a prognostic marker A Leisser, K Pruscha, P Ubl, W Wadsak, M Mayerhöfer, M Mitterhauser, ... The Prostate 75 (15), 1760-1767, 2015 | 31 | 2015 |
| CXCR4 PET/MRI for follow-up of gastric mucosa–associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication ME Mayerhoefer, M Raderer, W Lamm, M Weber, B Kiesewetter, ... Blood, The Journal of the American Society of Hematology 139 (2), 240-244, 2022 | 24 | 2022 |
| UTE‐mDixon‐based thorax synthetic CT generation KH Su, HT Friel, JW Kuo, R Al Helo, A Baydoun, C Stehning, AN Crisan, ... Medical physics 46 (8), 3520-3531, 2019 | 24 | 2019 |
| E. coli endotoxin modulates the expression of Sirtuin proteins in PBMC in humans A Storka, G Führlinger, M Seper, L Wang, M Jew, A Leisser, M Wolzt Mediators of Inflammation 2013, 2013 | 20 | 2013 |
| Analysis of hematological parameters as prognostic markers for toxicity and survival of 223Radium treatment A Leisser, M Nejabat, M Hartenbach, RAM Sareshgi, S Shariat, G Kramer, ... Oncotarget 9 (22), 16197, 2018 | 8 | 2018 |
| [11C]acetate PET as a tool for diagnosis of liver steatosis M Nejabat, A Leisser, G Karanikas, W Wadsak, M Mitterhauser, ... Abdominal Radiology 43, 2963-2969, 2018 | 7 | 2018 |
| Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer CP Spielvogel, S Stoiber, L Papp, D Krajnc, M Grahovac, E Gurnhofer, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (2), 546-558, 2023 | 5 | 2023 |
| Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves’ ophthalmopathy–a 1-year follow-up: study protocol for a randomized … L Brammen, P Riss, J Lukas, A Gessl, D Dunkler, S Li, A Leisser, ... Trials 19, 1-10, 2018 | 5 | 2018 |
| Single-Center Comparison of [64Cu]-DOTAGA-PSMA and [18F]-PSMA PET–CT for Imaging Prostate Cancer S Mirzaei, R Lipp, S Zandieh, A Leisser Current Oncology 28 (5), 4167-4173, 2021 | 4 | 2021 |
| E. coli endotoxin modulates the expression A Storka, G Führlinger, M Seper, L Wang, M Jew, A Leisser, M Wolzt | | |
